Ascendis Pharma A (ASND) Change in Working Capital (2015 - 2021)

Ascendis Pharma A (ASND) has 7 years of Change in Working Capital data on file, last reported at $2.4 million in Q1 2021.

• For the quarter ending Q1 2021, Change in Working Capital changed N/A year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2021 stood at -$45.9 million (changed N/A YoY), and the FY2020 full-year result was -$37.4 million, down 5.36% from the prior year.
• Change in Working Capital grew to $2.4 million in Q1 2021, from -$48.3 million in the prior quarter.
• In the past five years, Change in Working Capital ranged from a high of $2.4 million in Q1 2021 to a low of -$48.3 million in Q3 2020.
• A 5-year average of -$15.4 million and a median of -$9.2 million in 2017 frame the typical range for Change in Working Capital.
• Peak annual rise in Change in Working Capital reached 85.95% in 2017, while the deepest fall reached 6509.53% in 2017.
• Tracing ASND's Change in Working Capital over 5 years: stood at -$1.4 million in 2017, then slumped by 1061.91% to -$16.1 million in 2018, then tumbled by 123.58% to -$36.0 million in 2019, then plunged by 34.04% to -$48.3 million in 2020, then jumped by 104.95% to $2.4 million in 2021.
• Business Quant data shows ASND's Change in Working Capital at $2.4 million in Q1 2021, -$48.3 million in Q3 2020, and -$36.0 million in Q1 2019.